Patent · US Active

Circulating tumor cell assay

US8940493B2 · kind B2 · utility

1Cited by
9References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 29, 2007
Grant dateJan 27, 2015
Priority date
Expiry dateFeb 4, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods for the detection, enumeration and analysis of circulating tumor cells expressing insulin-like growth factor-1 receptors (IGF-1R) are disclosed. These methods are useful for cancer screening and staging, development of treatment regimens, and for monitoring for treatment responses, cancer recurrence or the like. Test kits that facilitate the detection, enumeration and analysis of such circulating tumor cells are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.